Tetraphase Pharmaceuticals to Present New Clinical and Preclinical Research on Its Antibiotic Portfolio at ICAAC
08:30 EDT 5 Sep 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Tetraphase
Pharmaceuticals, Inc., a clinical-stage life science company
developing novel antibiotics effective against antibiotic-resistant
bacteria, announced today that results of new research on several of its
next-gen...
Other Sources for this Article
Sam Brown Inc.
Media Contact:
Mike Beyer, 773-463-4211
beyer@sambrown.com
More From BioPortfolio on "Tetraphase Pharmaceuticals to Present New Clinical and Preclinical Research on Its Antibiotic Portfolio at ICAAC"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
